BIAMONTE, FLAVIA
 Distribuzione geografica
Continente #
EU - Europa 624
NA - Nord America 493
AS - Asia 61
Totale 1.178
Nazione #
US - Stati Uniti d'America 490
PL - Polonia 404
IT - Italia 102
IE - Irlanda 45
CN - Cina 34
SE - Svezia 34
FI - Finlandia 10
DE - Germania 9
GB - Regno Unito 7
CH - Svizzera 6
HK - Hong Kong 6
VN - Vietnam 6
AE - Emirati Arabi Uniti 3
CA - Canada 3
IN - India 3
JO - Giordania 3
SG - Singapore 3
TR - Turchia 3
BE - Belgio 2
RU - Federazione Russa 2
FR - Francia 1
NL - Olanda 1
UA - Ucraina 1
Totale 1.178
Città #
Warsaw 404
Fairfield 87
Ashburn 44
Dublin 44
Chandler 42
Catanzaro 40
Seattle 36
Woodbridge 32
Cambridge 31
Houston 28
Ann Arbor 23
Wilmington 23
Beijing 19
Lawrence 18
Altamura 17
Princeton 11
Buffalo 10
Boston 9
Shanghai 8
Bern 6
Dong Ket 6
Boardman 5
Florence 5
Jacksonville 5
Bremen 4
Cagliari 4
Hillsboro 4
San Diego 4
Abu Dhabi 3
Dearborn 3
Guidonia Montecelio 3
Medford 3
Paola 3
Pune 3
Reggio Calabria 3
Bisignano 2
Brussels 2
Catania 2
Guangzhou 2
Hong Kong 2
Milan 2
Nanjing 2
New York 2
Red Deer 2
Redwood City 2
Salerno 2
Scandale 2
Singapore 2
Andover 1
Aprilia 1
Bologna 1
Bracciano 1
Cantagallo 1
Corato 1
Eschweiler 1
Fuzhou 1
Greystones 1
Izmir 1
Kent 1
Kilburn 1
Laurel 1
Livorno 1
Nanchang 1
Norwalk 1
Old Bridge 1
Phoenix 1
Rome 1
Rotterdam 1
Shaoxing 1
Torino 1
Toronto 1
Totale 1.039
Nome #
MUTATIONS AND EPIGENETICS IN MYELOPROLIFERATIVE NEOPLASMS 256
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis. 228
Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells 175
Mutations and prognosis in primary myelofibrosis. 105
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 91
Epigenetics and mutations in chronic myeloproliferative neoplasms. 83
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. 77
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis 72
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 67
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. 40
Totale 1.194
Categoria #
all - tutte 2.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020283 22 29 7 22 31 24 34 31 23 28 29 3
2020/2021143 16 17 4 13 8 19 10 11 12 19 6 8
2021/202282 1 8 7 5 3 0 3 8 1 4 17 25
2022/2023261 17 41 9 15 20 37 32 20 21 38 4 7
2023/202462 6 9 10 0 5 9 3 13 0 3 2 2
Totale 1.194